Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is It Too Late to Buy McKesson Stock?


McKesson (NYSE: MCK), a healthcare supplier that was founded in 1833, is a value investor's dream. It has a relatively low valuation and strong long-term growth potential. Over the past three years, it also has delivered a total return of 485.64%.

The company has seen its shares rise more than 15% over the past year, though they have fallen more than 7% so far in 2023. McKesson recently raised its guidance for fiscal 2023, citing operational momentum.

The company's dividend isn't particularly generous, but its dependable revenue and net-income growth make it stand out. Considering the stock's sluggishness to start the year, does it still make sense to buy McKesson stock? Let's see.

Continue reading


Source Fool.com

Like: 0
MCK
Share

Comments